News | July 24, 2008

Inverness Medical Extends Distribution Agreement with Thermo Fisher Scientific

July 25, 2008 - Inverness Medical Innovations Inc. and Thermo Fisher Scientific have extended their cardiology products distribution relationship by two years through December 2010, which covers all cardiology and drugs of abuse rapid test products manufactured by Inverness’ subsidiary Biosite.

These tests are sold under the Triage brand and include tests for BNP, troponin, CK-MB, Myoglobin, d-dimer and a broad range of meter and visually read drugs of abuse tests.

Products sold for use on third party instruments, such as the BNP test sold by Inverness for use on Beckman immunoassay systems, are not included.

The modified financial terms of the new agreement were not disclosed.

For more information: www.invernessmedical.com.


Related Content

News | Angiography

Oct. 21, 2025 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...

Home October 24, 2025
Home
News | Angiography

Sept. 30, 2025 — Cleerly has announced that coverage policies from UnitedHealthcare and Cigna for Cleerly LABS advanced ...

Home September 30, 2025
Home
News | Angiography

July 28, 2025 — AngioDynamics, Inc. has announced enrollment of the first patient in the Randomized Study of the Auryon ...

Home July 28, 2025
Home
News | Angiography

April 25, 2025 — The annual Society for Cardiovascular Angiography & Interventions (SCAI) meeting, SCAI 2025 Scientific ...

Home April 25, 2025
Home
News | Angiography

March 17, 2025 – Ostial Corp., a privately held medical technology company focused on addressing the clinical challenges ...

Home March 18, 2025
Home
News | Angiography

SCAI Scientific Sessions 2025 will take place May 1 to 3, at the Walter E. Washington Convention Center in Washington ...

Home March 14, 2025
Home
News | Angiography

Oct. 7, 2024 — The Society for Cardiovascular Angiography & Interventions (SCAI) recently announced the publication of ...

Home October 07, 2024
Home
News | Angiography

January 31, 2024 — Coronary artery calcification is increasing in prevalence, leading to greater risks both during ...

Home January 31, 2024
Home
Feature | Angiography | By Bhvita Jani

The world market for interventional X-ray and mobile C-arm equipment is forecast to reach over $4.9 billion by 2026 ...

Home November 09, 2022
Home
News | Angiography
April 6, 2022 – According to ARRS’ American Journal of Roentgenology (AJR), the 3-T Dixon gradient-recalled echo (GRE) ...
Home April 06, 2022
Home
Subscribe Now